Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check2 days agoChange DetectedA new Lancet Oncology TALAPRO-1 citation was added to the Publications section. The earlier Lancet Oncology entry, including its erratum, was removed.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI rather than any study information.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a new Lancet Oncology TALAPRO-1 publication citation (de Bono et al., 2021) with an erratum in 2022 and updated the revision to v3.5.2. Removed the older TALAPRO-1 citation with revision v3.5.0.SummaryDifference0.0%

- Check45 days agoChange DetectedLocation entry updated from Padua, Italy, 35128 to Padova, Italy, 35128. The site name now uses the local Italian spelling.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved related topics: Prostate cancer and MedlinePlus Genetics from the related topics section.SummaryDifference0.1%

- Check60 days agoChange DetectedUpdated the Italy location listing from Napoli, Italy (80131) to Naples, Italy (80131) (Naples, 80131 added; Napoli, 80131 removed). Added related topics: Prostate cancer and MedlinePlus Genetics.SummaryDifference0.1%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.